113 related articles for article (PubMed ID: 28845972)
21. Towards multifunctional, targeted drug delivery systems using mesoporous silica nanoparticles--opportunities & challenges.
Rosenholm JM; Sahlgren C; Lindén M
Nanoscale; 2010 Oct; 2(10):1870-83. PubMed ID: 20730166
[TBL] [Abstract][Full Text] [Related]
22. Shape matters when engineering mesoporous silica-based nanomedicines.
Hao N; Li L; Tang F
Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
[TBL] [Abstract][Full Text] [Related]
23. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
Giret S; Wong Chi Man M; Carcel C
Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
[TBL] [Abstract][Full Text] [Related]
24. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
[TBL] [Abstract][Full Text] [Related]
25. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of mesoporous hollow silica nanospheres using polymeric micelles as template and their application as a drug-delivery carrier.
Sasidharan M; Zenibana H; Nandi M; Bhaumik A; Nakashima K
Dalton Trans; 2013 Oct; 42(37):13381-9. PubMed ID: 23887599
[TBL] [Abstract][Full Text] [Related]
27. Biosafety evaluations of well-dispersed mesoporous silica nanoparticles: towards in vivo-relevant conditions.
Liu TP; Wu SH; Chen YP; Chou CM; Chen CT
Nanoscale; 2015 Apr; 7(15):6471-80. PubMed ID: 25804371
[TBL] [Abstract][Full Text] [Related]
28. In situ biodegradable crosslinking of cationic oligomer coating on mesoporous silica nanoparticles for drug delivery.
Wang Y; Wang J; Yang Y; Sun Y; Yuan Y; Li Y; Liu C
Colloids Surf B Biointerfaces; 2017 May; 153():272-279. PubMed ID: 28279933
[TBL] [Abstract][Full Text] [Related]
29. Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores.
Na HK; Kim MH; Park K; Ryoo SR; Lee KE; Jeon H; Ryoo R; Hyeon C; Min DH
Small; 2012 Jun; 8(11):1752-61. PubMed ID: 22454257
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of coesite nanocrystals from ethane bridged periodic mesoporous organosilica at low temperature and extreme pressure.
Liang Z; Mohanty P; Fei Y; Landskron K
Chem Commun (Camb); 2010 Dec; 46(46):8815-7. PubMed ID: 20953487
[TBL] [Abstract][Full Text] [Related]
31. Ordered mesoporous platinum@graphitic carbon embedded nanophase as a highly active, stable, and methanol-tolerant oxygen reduction electrocatalyst.
Wu Z; Lv Y; Xia Y; Webley PA; Zhao D
J Am Chem Soc; 2012 Feb; 134(4):2236-45. PubMed ID: 22257228
[TBL] [Abstract][Full Text] [Related]
32. Hierarchically mesoporous silica nanoparticles: extraction, amino-functionalization, and their multipurpose potentials.
Du X; He J
Langmuir; 2011 Mar; 27(6):2972-9. PubMed ID: 21332153
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of mesoporous silica nanobamboo with highly dispersed tungsten carbide nanoparticles.
Huang Y; Deng F; Ni C; Chen JG; Vlachos DG
Dalton Trans; 2012 Jun; 41(23):6914-8. PubMed ID: 22532100
[TBL] [Abstract][Full Text] [Related]
34. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.
Liu J; Luo Z; Zhang J; Luo T; Zhou J; Zhao X; Cai K
Biomaterials; 2016 Mar; 83():51-65. PubMed ID: 26773665
[TBL] [Abstract][Full Text] [Related]
35. Mesoporous silica nanoparticles with manipulated microstructures for drug delivery.
Chen Z; Li X; He H; Ren Z; Liu Y; Wang J; Li Z; Shen G; Han G
Colloids Surf B Biointerfaces; 2012 Jun; 95():274-8. PubMed ID: 22494670
[TBL] [Abstract][Full Text] [Related]
36. Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery.
Chen C; Geng J; Pu F; Yang X; Ren J; Qu X
Angew Chem Int Ed Engl; 2011 Jan; 50(4):882-6. PubMed ID: 21246683
[No Abstract] [Full Text] [Related]
37. An anti-ROS/hepatic fibrosis drug delivery system based on salvianolic acid B loaded mesoporous silica nanoparticles.
He Q; Zhang J; Chen F; Guo L; Zhu Z; Shi J
Biomaterials; 2010 Oct; 31(30):7785-96. PubMed ID: 20674009
[TBL] [Abstract][Full Text] [Related]
38. Cytochrome c end-capped mesoporous silica nanoparticles as redox-responsive drug delivery vehicles for liver tumor-targeted triplex therapy in vitro and in vivo.
Zhang B; Luo Z; Liu J; Ding X; Li J; Cai K
J Control Release; 2014 Oct; 192():192-201. PubMed ID: 25034575
[TBL] [Abstract][Full Text] [Related]
39. The comparative effects of mesoporous silica nanoparticles and colloidal silica on inflammation and apoptosis.
Lee S; Yun HS; Kim SH
Biomaterials; 2011 Dec; 32(35):9434-43. PubMed ID: 21889200
[TBL] [Abstract][Full Text] [Related]
40. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]